Patent details

Basic Information

Publication number:

EP1575618

PCT Application Number:

PCT/US/2003/039508

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP038147286

PCT Publication Number:

WO/2004/060345

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

DISPERSIBLE PHARMACEUTICAL COMPOSITIONS

French Title of Invention:

COMPOSITIONS PHARMACEUTIQUES DISPERSIBLES

German Title of Invention:

DISPERGIERBARE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN

SPC Number:

Dates

Filing date:

11/12/2003

Grant date:

16/08/2006

EP Publication Date:

16/08/2006

PCT Publication Date:

22/07/2004

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

21/09/2005

EP B1 Publication Date:

16/08/2006

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

11/12/2009

Expiration date:

11/12/2023

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

28/12/2006

 

 

Name:

Pharmacia & Upjohn Company LLC

Address:

7000 Portage Road, Kalamazoo, MI 49001, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

17/08/2006

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

BRITTEN Nancy J., Pfizer Global Research & Dev.

Address:

United States (US)

2

Name:

BURNS John W., Pfizer Global Research & Dev.

Address:

United States (US)

3

Name:

WALDRON Niki A., Pfizer Global Research & Dev.

Address:

United States (US)

Priority

1

Priority Number:

434985 P

Priority Date:

19/12/2002

Priority Country:

United States (US)

2

Priority Number:

687986

Priority Date:

17/10/2003

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 47/44;

Filing date	Document type	Number of pages